Back to today’s briefing

Story perspectives

Bristol Firm Secures £4.5M to Revolutionize Isotope Production

2/6/2025

29 6

Summary

Story summary

Bristol's Astral Systems has secured £4.5 million to revolutionize medical isotope production with compact nuclear fusion reactors. Co-founders Talmon Firestone and Dr. Tom Wallace-Smith are tackling shortages from aging reactors, offering a groundbreaking solution that enhances efficiency and reduces costs, potentially transforming cancer treatment and hybrid nuclear energy.

1 of 1

Story summary

Bristol's Astral Systems has secured £4.5 million to revolutionize medical isotope production with compact nuclear fusion reactors. Co-founders Talmon Firestone and Dr. Tom Wallace-Smith are tackling shortages from aging reactors, offering a groundbreaking solution that enhances efficiency and reduces costs, potentially transforming cancer treatment and hybrid nuclear energy.